Skip to NavigationSkip to content

RareCan appoints Dr Anita Cooper as Non-Executive Director

Published on: 25/08/21

Cancer research company RareCan has appointed Dr Anita Cooper as Non-Executive Director.

Cooper has over 30 years’ experience in global business and is currently a Non-Executive Director for Simbec-Orion, a leading Clinical Research Organisation.

Piers Kotting, CEO of RareCan, commented: “We are thrilled to welcome Anita to the Board of RareCan. Anita’s wealth of industry experience will help us to accelerate rare cancer research by maximising the value of RareCan to both the global life sciences and pharmaceutical services industries.”

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches